Literature DB >> 29352538

The promise and challenges of drug repurposing in psychiatry.

Maurizio Fava1.   

Abstract

Year:  2018        PMID： 29352538      PMCID： PMC5775121          DOI： 10.1002/wps.20481

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  8 in total

1.  Evergreening, patent challenges, and effective market life in pharmaceuticals.

Authors:  C Scott Hemphill; Bhaven N Sampat
Journal:  J Health Econ       Date:  2012-02-09       Impact factor: 3.883

2.  An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder.

Authors:  T Spencer; J Biederman; J Heiligenstein; T Wilens; D Faries; J Prince; S V Faraone; J Rea; J Witcher; S Zervas
Journal:  J Child Adolesc Psychopharmacol       Date:  2001       Impact factor: 2.576

Review 3.  [Brief history of the development of valproate in bipolar disorders].

Authors:  T Lempérière
Journal:  Encephale       Date:  2001 Jul-Aug       Impact factor: 1.291

4.  A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.

Authors:  J Biederman; R J Baldessarini; V Wright; D Knee; J S Harmatz
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1989-09       Impact factor: 8.829

5.  Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies.

Authors:  Christopher E M Griffiths; Maurizio Fava; Andrew H Miller; James Russell; Susan G Ball; Wen Xu; Nayan Acharya; Mark Hyman Rapaport
Journal:  Psychother Psychosom       Date:  2017-09-14       Impact factor: 17.659

Review 6.  Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience.

Authors:  L Ferry; J A Johnston
Journal:  Int J Clin Pract       Date:  2003-04       Impact factor: 2.503

7.  Filling the gap in CNS drug development: evaluation of the role of drug repurposing.

Authors:  A Caban; K Pisarczyk; K Kopacz; A Kapuśniak; M Toumi; C Rémuzat; A Kornfeld
Journal:  J Mark Access Health Policy       Date:  2017-04-10

8.  Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature.

Authors:  Susana Murteira; Zied Ghezaiel; Slim Karray; Michel Lamure
Journal:  J Mark Access Health Policy       Date:  2013-08-06
  8 in total
  7 in total

1.  The Role of Precision Medicine in Child Psychiatry: What Can We Expect and When?

Authors:  Jonathan Posner
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-11       Impact factor: 8.829

2.  Transcriptome-wide association analysis offers novel opportunities for clinical translation of genetic discoveries on mental disorders.

Authors:  Eske M Derks; Eric R Gamazon
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

Review 3.  Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents.

Authors:  Sha Zhu; Qifeng Bai; Lanqing Li; Tingyang Xu
Journal:  Comput Struct Biotechnol J       Date:  2022-06-01       Impact factor: 6.155

Review 4.  "Novel Psychopharmacology for Depressive Disorders".

Authors:  Michele Fornaro; Domenico De Berardis; Annalisa Anastasia; Andrea Fusco
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Signature-based approaches for informed drug repurposing: targeting CNS disorders.

Authors:  Rammohan Shukla; Nicholas D Henkel; Khaled Alganem; Abdul-Rizaq Hamoud; James Reigle; Rawan S Alnafisah; Hunter M Eby; Ali S Imami; Justin F Creeden; Scott A Miruzzi; Jaroslaw Meller; Robert E Mccullumsmith
Journal:  Neuropsychopharmacology       Date:  2020-06-30       Impact factor: 8.294

Review 6.  Old Drugs as New Treatments for Neurodegenerative Diseases.

Authors:  Fernando Durães; Madalena Pinto; Emília Sousa
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-11

7.  Genetics of substance use disorders: a review.

Authors:  Joseph D Deak; Emma C Johnson
Journal:  Psychol Med       Date:  2021-04-21       Impact factor: 7.723
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.